Founded in Boston, BostonMolecules Inc. is committed to providing exceptional product quality and unsurpassed customer services. Through scientific innovation and customer Co-evolution of trust and dependence, we are shaping the landscape of biomedical research.
With over 20 years of experience in developing custom antibodies, proteins and peptides, we provides a comprehensive service program that covers monoclonal antibody development from mouse hybridoma technology to rabbit B-cells cloning technology; Protein Services from recombinant protein production to downstream protein Crystallography; Peptide services from peptide synthesis, labeling, peptide library and GMP peptide. Our unique and powerful Z-Active protein expression platform allows us to provide superb cytokine and growth factor products.
Company Details
- Address
- 204 2nd Ave.,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bostonmolecules.com
- HQ
- Waltham, MA
Boston Molecules Inc. Questions
Boston Molecules Inc.'s website is http://www.bostonmolecules.com
Boston Molecules Inc.'s LinkedIn profile is https://www.linkedin.com/company/boston-molecules-inc
Boston Molecules Inc.'s industry is
Biotechnology Research
Boston Molecules Inc.'s top competitors are
Entrada Therapeutics,
Stark,
Crispr Therapeutics,
Radx,
Kojin Therapeutics,
Cell Signaling Technology (Cst),
New England Peptide | Peptides International,
New England Biolabs,
Apogee Therapeutics,
Elevatebio.
Boston Molecules Inc.'s categories are Biotechnology Research
